Goldman Sachs Added Albemarle (ALB) to their Conviction Buy List
More News related to ALB
- Albemarle to Increase Ibuprofen Prices
- Albemarle Scientists Named 'Heroes of Chemistry'
- Albemarle (ALB) Increases Prices of Select ETHACURE Curatives Worldwide
- Albemarle to Increase Prices of ETHACURE(R) Curatives
- Albemarle to Increase Prices of Brominated Flame Retardants
More News related to Analyst Comments
- Buckingham Research Maintains an 'Accumulate' on Church & Dwight (CHD), Increases Price Target
- ARGUS Maintains 'Buy' Rating on General Electric (GE), Positive on Strong Olympic Revenues
- Boeing (BA) Sinks On Machinists Strike; Company May Have To Pay Up
- Credit Card Stocks Sink After Lehamn Cuts Estimates/Targets, Saying More Charge-Offs Are Coming in '09
- Deutsche Bank Says Buy Coca-Cola (KO) On Recent Weakness
This morning, Goldman Sachs added Albemarle (NYSE: ALB) to their Conviction Buy List.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals. It operates in three segments: Polymer Additives, Catalysts, and Fine Chemicals.
Related Categories
Analyst CommentsStocks Mentioned
-1.28Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
